Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance.
about
Cardiac magnetic resonance imaging for the investigation of cardiovascular disorders. Part 1: current applications.Guideline of transthyretin-related hereditary amyloidosis for clinicians.Senile systemic amyloidosis: clinical features at presentation and outcome.Noninvasive molecular imaging of cell death in myocardial infarction using 111In-GSAO.The relative atrial volume ratio and late gadolinium enhancement provide additive information to differentiate constrictive pericarditis from restrictive cardiomyopathy.Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.Cardiovascular magnetic resonance and prognosis in cardiac amyloidosisMagnetic resonance imaging of cardiovascular fibrosis and inflammation: from clinical practice to animal studies and backDiagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosisIdentifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.MRI assessment of cardiac amyloidosis: experience of six cases with review of the current literature.Incidence, diagnosis and prognosis of cardiac amyloidosis.CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis.The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.Cardiac amyloidosis: the heart of the matter.Emerging concepts for myocardial late gadolinium enhancement MRI.How to diagnose amyloidosis.Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction.The transthyretin amyloidoses: advances in therapy.Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology.Improving strategies for the diagnosis of cardiac amyloidosis.Cardiac Amyloidosis: Diagnosis and Treatment Strategies.Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging.An unusual case of cardiac amyloidosis.Author reply--an unusual case of cardiac amyloidosis.Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings.Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis.Early Impairment of Cardiac Function and Asynchronization of Systemic Amyloidosis with Preserved Ejection Fraction Using Two-Dimensional Speckle Tracking Echocardiography.Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease.Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.Cardiac Amyloidosis Diagnosis with Magnetic Resonance Imaging: A Case Report.Familial and Senile Amyloidosis Caused by TransthyretinNew pathological insights into cardiac amyloidosis: implications for non-invasive diagnosisCardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosisNoninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study
P2860
Q30432349-03A7ADD2-D011-4BDE-9ABB-3E01D0B1792AQ34328734-179D2B87-1F40-4EA4-BFDB-9B1FE100231EQ34340740-8D59C78C-AC0E-4C07-977B-769CD384943CQ34417492-CDA2E32A-64C0-47BB-A678-C773A4D447A9Q34677424-9FE35E2F-3E64-47DD-AC14-3308F38368B7Q36367005-1CCE4850-1547-445A-A51F-47B31EB4D1C5Q37020261-47584FDF-1ABD-4FA3-B99F-777AC86CC038Q37154775-B35F8EA9-1B66-400C-9DAE-AC478AF778D9Q37186950-9B7ECE3E-15CD-4E6E-84C3-16D79A18B4DBQ37248274-4E3DE4C2-EBA5-4970-9BCF-5CEF726B76F4Q37333390-4EB79CB9-FE1E-4AB9-9BA2-682DEB25888FQ37399628-15F93FBE-75D2-4568-A34D-B2AFEF78503AQ37633748-530929E7-305B-4EA5-B6E0-A79C8E7910DBQ37822294-7292E2F1-D57C-40BB-ACC4-3747B82EB23BQ37899075-6F0BADFA-7D70-4A29-93F5-B4C7FBEE077FQ38126089-9312D7D5-CF2C-44E7-AD66-B5E0285D70E7Q38136289-F7179946-84C6-4A80-A737-056EDF3264C2Q38450940-0AC2A18D-0963-4A21-836A-7F92F9AE9D6EQ38517905-E99E3ACC-DDAF-4D1E-9A00-81A791166E6EQ38532386-4624895C-23E3-434F-B18E-6139D01E969EQ38547033-22A75459-9C83-4233-B580-3E9716550DFEQ39320411-9C44DB66-F95D-4274-A09C-1F2C1762A9FBQ39754493-3BB9B48A-6D50-458D-8D17-DB0C8B81E907Q41186489-B97B2B77-68F7-4A80-9F38-40BD362F89E6Q41272712-9CFBD5FD-AF17-4640-92CF-9610CFBBFFEBQ41686949-95C7437A-EAA6-43C3-8BD6-3ECCF3A6506EQ42987768-09AD045A-521E-4290-9527-AB643DAC0172Q42987784-C6AD8459-DBB2-4ACB-9DFF-9A9C875F3CF7Q46526071-F84E0E5B-35B2-4B7B-AF3E-4A51DBDD66B0Q48404782-4C3857E0-BE9D-4E3E-BF2A-E6B784F92E05Q48667105-347CB652-2B5E-4E8F-B3FE-4918D38B0E81Q51228133-34902124-2100-42A7-8F13-8635DCD49163Q52894311-062BC0F6-601A-4AAA-BE53-BB02BA115237Q55271656-612DC0B8-2547-4748-BE78-04DC56DA230CQ56031907-FF1A147C-E29D-4DD5-AD4C-571C3BAAF95BQ56981390-6949FCBC-D8F7-4995-9DBF-9B321F5A2BCEQ56986003-21AF7C05-42EC-46B6-96D4-B76B0845B2A8Q58125154-C76A1749-91BB-4574-B5DB-65EC68C1E699
P2860
Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Non-invasive evaluation of the ...... um cardiac magnetic resonance.
@ast
Non-invasive evaluation of the ...... um cardiac magnetic resonance.
@en
type
label
Non-invasive evaluation of the ...... um cardiac magnetic resonance.
@ast
Non-invasive evaluation of the ...... um cardiac magnetic resonance.
@en
prefLabel
Non-invasive evaluation of the ...... um cardiac magnetic resonance.
@ast
Non-invasive evaluation of the ...... um cardiac magnetic resonance.
@en
P2093
P2860
P356
P1433
P1476
Non-invasive evaluation of the ...... um cardiac magnetic resonance.
@en
P2093
E Perugini
L Bacchi-Reggiani
P2860
P304
P356
10.1136/HRT.2005.061911
P407
P577
2005-06-06T00:00:00Z